RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
复制标题
RhoC 是 microRNA-93-5P 在上皮性卵巢癌肿瘤发生和进展中的主要靶标
DOI:
10.1186/s12943-015-0304-6
复制
发表时间:
2015-02-04
期刊:
影响因子:
37.3
通讯作者:
Zhao Y
中科院分区:
文献类型:
--
作者:
Chen X;Chen S;Xiu YL;Sun KX;Zong ZH;Zhao Y
An increasing amount of evidence has revealed that microRNAs regulate various biological processes, including cell differentiation, cell proliferation, apoptosis, drug resistance, and fat metabolism. Studies have shown that miR-93’s targetome in cancer has not been fully defined. Moreover, the role of miR-93 in epithelial ovarian carcinoma (EOC) remains largely unknown. MIR-93 mRNA expression in normal ovarian tissue, benign tumors, borderline tumors, primary ovarian carcinomas, and metastatic omentum was quantified. The ovarian carcinoma cell lines OVCAR3, SKOV3/DDP, and HO8910-PM were transfected with miR-93-5P, after which cell phenotype and expression of relevant molecules were assayed. Dual-luciferase reporter assay and a xenograft mouse model were used to examine miR-93 and its target gene RHOC (Ras homolog gene family member C). MIR-93 mRNA expression was significantly lower in ovarian carcinomas and borderline tumors than in normal ovarian tissues (p < 0.05), and was lower in metastatic omentum than in relative primary ovarian carcinomas (p < 0.05). MIR-93 mRNA expression was also negatively associated with differentiation (well vs. poor and moderate) and International Federation of Gynecology and Obstetrics staging (FIGO stage I/II vs. stage III/IV) in ovarian carcinoma (p < 0.05), besides, miR-93 was higher expressed in mucinous adenocarcinoma than the other types (p < 0.05). MiR-93-5P overexpression reduced proliferation (p < 0.05); promoted G1 or S arrest and apoptosis (p < 0.05); suppressed migration and invasion (p < 0.05); and reduced RhoC, P70S6 kinase, Bcl-xL, matrix metalloproteinase 9 (MMP9) mRNA or protein expression; conversely, it induced P53 and cleaved PARP expression (p < 0.05). Dual-luciferase reporter assay indicated that miR-93 directly targeted RhoC by binding its 3′ untranslated region. MiR-93-5P transfection also suppressed tumor development and RhoC expression (determined by immunohistochemistry) in vivo in the xenograft mouse model (p < 0.05). This is the first demonstration that miR-93-5P may inhibit EOC tumorigenesis and progression by targeting RhoC. These findings indicate that miR-93-5P is a potential suppressor of ovarian cellular proliferation. The involvement of miR-93-5P–mediated RhoC downregulation in inhibiting EOC aggressiveness may provide extended insight into the molecular mechanisms underlying cancer aggressiveness.
登录
查看更多内容
影响因子:
3.7
作者:
Sanchez-Diaz PC;Hsiao TH;Chang JC;Yue D;Tan MC;Chen HI;Tomlinson GE;Huang Y;Chen Y;Hung JY
通讯作者:
Hung JY
影响因子:
11.5
作者:
Nam, Eun Ji;Yoon, Heejei;Kim, Sunghoon
通讯作者:
Kim, Sunghoon
影响因子:
4.8
作者:
Long, Jianyin;Wang, Yin;Danesh, Farhad R.
通讯作者:
Danesh, Farhad R.
DOI:
10.1158/1541-7786.mcr-08-0512
发表时间:
2009-11
期刊:
Molecular cancer research : MCR
影响因子:
--
作者:
Islam M;Lin G;Brenner JC;Pan Q;Merajver SD;Hou Y;Kumar P;Teknos TN
通讯作者:
Teknos TN
影响因子:
7.3
作者:
Farazi, Thalia A.;Spitzer, Jessica I.;Morozov, Pavel;Tuschl, Thomas
通讯作者:
Tuschl, Thomas